The effect of betahistine on post-operative nausea and vomiting in patients undergoing laparascopic cholecystectomy

The effect of betahistine on post-operative nausea and vomiting in pateints undergoing laparascopic cholecystectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170408033280N2

Enrollment

Registered

2019-01-02

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post -Operative Nausea and Vomiting.

Interventions

Intervention 1: Intervention group:Administration of 8 mg oral Beta-histein 90 minutes before surgery. Intervention 2: Control group: Oral administration of the placebo 90 minutes before surgery.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: patients undergoing laparascopic cholecystectomy from 20 to 60 years

Exclusion criteria

Exclusion criteria: ?Asthma Pheochromocytoma Gastroesophageal reflux severe obesity difficult airway pregnancy lactation liver and kidney diseases history of drug addiction and alcoholism neuromuscular diseases Psychiatric disorders diabetes mellitus gastrointestinal obstruction Alcoholism

Design outcomes

Primary

Measure	Time frame
Postoperative nausea and vomiting. Timepoint: Every 30 minutes\vsakhli. Method of measurement: ?Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEbrahim Hassani

Oroumia University of Medical Sciences

ehassani87@gmail.com+98 44 3346 8967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026